Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2002-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation
may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation
plus combination chemotherapy in treating patients who have multiple myeloma.
Phase:
Phase 2
Details
Lead Sponsor:
University of Maryland Greenebaum Cancer Center University of Maryland, Baltimore